merimepodib
Showing 1 - 2 of 2
COVID-19 Trial in United States (Merimepodib, Matching Placebo, Remdesivir)
Terminated
- COVID-19
- Merimepodib
- +2 more
-
Phoenix, Arizona
- +9 more
Dec 4, 2020
Hepatitis C, Hepatitis Trial in United States (Merimepodib, PEG-Interferon-alpha 2a (Pegasys®), Ribavirin (Copegus®))
Completed
- Hepatitis C
- Hepatitis
- Merimepodib
- +2 more
-
Birmingham, Alabama
- +66 more
Dec 17, 2007